Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literature
| Autor: | Laura Elisa Gasparini, Daniela Abbati, Milo Gatti, Francesco Scaglione, Roberto Fumagalli, Paolo Brioschi, Stefano Clemente, Chiara Grimaldi |
|---|---|
| Přispěvatelé: | Gatti, M, Gasparini, L, Grimaldi, C, Abbati, D, Clemente, S, Brioschi, P, Fumagalli, R, Scaglione, F, Gatti M., Gasparini L.E., Grimaldi C.M., Abbati D., Clemente S., Brioschi P.R., Fumagalli R., Scaglione F. |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Necrotizing soft tissue infection 030106 microbiology Therapeutic drug monitoring Actinomycosi Actinomycosis law.invention 03 medical and health sciences 0302 clinical medicine law Septic shock Antibiotic therapy Anti-Bacterial Agent Actinomyces Turicensi medicine Actinomyces Humans Pharmacology (medical) 030212 general & internal medicine Actinomyce Intensive care medicine Pharmacology Clinical pharmacology medicine.diagnostic_test business.industry Soft Tissue Infections Clinical Pharmacology Middle Aged medicine.disease Shock Septic Anti-Bacterial Agents Infectious Diseases Debridement Oncology NSTI Pharmacology Clinical Ampicillin Female Actinomyces turicensis business Human |
| Zdroj: | Journal of Chemotherapy. 29:372-375 |
| ISSN: | 1973-9478 1120-009X |
| DOI: | 10.1080/1120009x.2017.1306154 |
| Popis: | Critical septic patients affected by necrotizing soft tissue infections (NSTI) require an early, aggressive and multidisciplinary treatment. Pharmacokinetic alterations in antibiotic therapy are peculiar in these infections. Clinical pharmacology represents a first step in this setting. We report a case of septic shock due to NSTI in which clinical pharmacology is taken into account. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|